All
Virtual trial designed to explore AMD monitoring
February 3rd 2016Constructing vignettes from retina images and data can serve as a useful low-cost alternative to clinical trials for evaluating different screening approaches, researchers said. The researchers, from seven British medical centres, have taken this approach in a virtual trial to determine whether community optometrists can assess the risk that quiescent neovascular age-related macular degeneration (AMD) lesions can reawaken.
Managing challenges in giant retinal tear re-attachment
January 26th 2016Giant retinal tears pose outsize challenges for physicians, including the risks of hemorrhage, heavy fluid droplets, and macular holes, according to Gerardo Ledesma-Gil, MD, who was challenged with both of these complications in a recent case.
Year brings advances in retinal imaging, screening, and gene/drug therapies
December 9th 2015The topics of special interest to retina specialists during 2015 include optical coherence tomography angiography (OCTA) and screening for retinopathy of prematurity (ROP). Important research is taking place to determine the etiology of angiogenesis, possibly leading to targeting therapies in age-related macular degeneration (AMD), ROP, and diabetic retinopathy.
Persistent subfoveal fluid following successful macular hole surgery
December 1st 2015The presence of subretinal fluid following successful macular hole surgery appears to be common, and may be associated with delayed visual recovery, although not with the final result. Smaller holes and vitreofoveal traction are significant risk factors associated with increased rates of postoperative foveal detachment.
DRCR.net retinal treatment results take center stage in 2015
December 1st 2015Studies of the efficacy of anti-vascular endothelial growth factor (VEGF), gene therapies, and slow-release drug delivery systems took center stage among treatments for retinal disorders in 2015. In addition to studies already under way, others are about to begin.
Bone marrow cells show promise in degenerative, ischemic retinal diseases
June 15th 2015The safety and feasibility of intravitreal autologous CD34+ bone marrow cells as a potential therapy for retinal disease were evaluated in a pilot study. Preliminary findings demonstrated the treatment was feasible and researchers intend to pursue a larger, prospective study with longer follow-up.
Pars plana vitrectomy makes paradigm shift for retinal surgery in Europe
June 15th 2015European retinal surgeons have been shifting to the use of pars plana vitrectomy for the repair of rhegmatogenous retinal detachment, but scleral buckle surgery is still a viable choice in young and uncomplicated cases.
Nitrosative & oxidative stress is associated with structural changes
June 10th 2015In this article, the authors present their recent study results. The study findings demonstrated, for the first time, that in vivo structural changes in ISel band and RPE are associated with increased plasma nitrosative and oxidative stress.
Trending Now: Hottest surgery stories of 2014
December 25th 2014The hottest stories in surgery this year included news about cataract surgery by a charity-run Indian camp cost at least 24 elderly people their eyesight, how to correct RK, and how to identify and manage dysphotopsia after cataract surgery.
Retinal vein occlusion treatment undergoes paradigm shift with pharmacotherapy
November 1st 2014Based on findings from a series of clinical trials in recent years, pharmacotherapy has supplanted both laser photocoagulation and a watchful waiting approach as the first-line therapy for retinal vein occlusion.
Jackson Memorial Lecture: Past, present and future outlook of retinoblastoma
October 19th 2014“Retinoblastoma is a remarkable ophthalmology success story in which the efforts of ophthalmologists, ophthalmic pathologists, and research scientists have led to understanding of the basic mechanisms of cancer and targeted therapies that are able to cure a once incurable tumor,” said Hans E. Grossniklaus, MD, MBA. He was honored as the recipient of the 71st Jackson Memorial Lecture Award in the opening session of the annual meeting of the American Academy of Ophthalmology.